CWM
ALXN

CIBC World Markets’s Alexion Pharmaceuticals ALXN Stock Holding History

CIBC World Markets’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,741
Closed -$3.26M – 640
2021
Q2 		$3.26M Sell
17,741
-361,625
-95% -$62.1M 0.02% 335
2021
Q1 		$58M Buy
379,366
+319,477
+533% +$49.4M 0.36% 54
2020
Q4 		$9.36M Sell
59,889
-378,643
-86% -$48.7M 0.05% 249
2020
Q3 		$50.2M Buy
438,532
+402,567
+1,119% +$43.4M 0.49% 52
2020
Q2 		$4.04M Buy
35,965
+1,479
+4% +$157K 0.04% 283
2020
Q1 		$3.1M Sell
34,486
-19,248
-36% -$1.89M 0.04% 274
2019
Q4 		$5.81M Sell
53,734
-34,896
-39% -$3.73M 0.04% 367
2019
Q3 		$8.68M Buy
88,630
+5,093
+6% +$574K 0.08% 242
2019
Q2 		$10.9M Buy
83,537
+30,044
+56% +$3.87M 0.08% 253
2019
Q1 		$7.23M Sell
53,493
-20,510
-28% -$2.55M 0.06% 275
2018
Q4 		$7.21M Buy
74,003
+7,000
+10% +$827K 0.07% 247
2018
Q3 		$9.31M Buy
67,003
+17,554
+35% +$2.2M 0.08% 231
2018
Q2 		$6.14M Buy
49,449
+8,356
+20% +$977K 0.05% 315
2018
Q1 		$4.58M Sell
41,093
-25,164
-38% -$3.01M 0.05% 308
2017
Q4 		$7.92M Buy
66,257
+15,331
+30% +$1.87M 0.06% 246
2017
Q3 		$7.14M Buy
50,926
+2,528
+5% +$343K 0.07% 223
2017
Q2 		$5.89M Sell
48,398
-132,778
-73% -$15.5M 0.06% 263
2017
Q1 		$22M Buy
181,176
+165,783
+1,077% +$21.4M 0.18% 104
2016
Q4 		$1.88M Buy
15,393
+11,055
+255% +$1.35M 0.02% 306
2016
Q3 		$532K Sell
4,338
-10,754
-71% -$1.38M 0.01% 221
2016
Q2 		$1.76M Buy
15,092
+1,293
+9% +$183K 0.05% 134
2016
Q1 		$1.92M Sell
13,799
-5,175
-27% -$760K 0.04% 133
2015
Q4 		$3.62M Buy
18,974
+3,324
+21% +$581K 0.07% 139
2015
Q3 		$2.45M Buy
15,650
+9,915
+173% +$1.81M 0.07% 145
2015
Q2 		$1.04M Buy
+5,735
New +$990K 0.03% 124

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

CIBC World Markets's ALXN Position: Q3 2021 in Review

CIBC World Markets sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 17,741 shares — an estimated $3.26M sold.

CIBC World Markets first reported a position in ALXN in Q2 2015 and held it in 25 quarters. The position peaked at $58M in Q1 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • CIBC World Markets reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • CIBC World Markets sold 17,741 Alexion Pharmaceuticals shares in Q3 2021, an estimated $3.26M.
  • CIBC World Markets first reported a position in Alexion Pharmaceuticals in Q2 2015 and held it in 25 quarters.
  • CIBC World Markets's Alexion Pharmaceuticals position peaked at $58M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on CIBC World Markets's 13F filing for Q3 2021, filed 12 Nov 2021.